← Open Payments lookup

WILLIAM MANN: Open Payments

NPI 1649211715 · WILSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$838 in 46 payments from 10 companies in 2025. Trend: 2023 $1,784 · 2024 $1,211 · 2025 $838

Food & beverage: $838
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc13$280
Teva Pharmaceuticals USA, Inc.17$215
Alkermes, Inc.4$85
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49
E.R. Squibb & Sons, L.L.C.2$43
Luye Pharma (USA) Ltd.2$43
Otsuka America Pharmaceutical, Inc.2$40
Neurocrine BioSciences, Inc.2$38
Noven Therapeutics, LLC1$25
Vanda Pharmaceuticals Inc.1$21

Products named: INVEGA SUSTENNA, AUSTEDO XR, ARISTADA, UZEDY, CAPLYTA, COBENFY, ERZOFRI EXTENDED-RELEASE, INGREZZA.

Industry payments across NC — which companies pay providers there.